Similar to our findings, Khedr et al. (2022) reported that DCN was upregulated; however, CTC-448F2.4 and miR1273a were downregulated in MI/R, contributing to fibrosis and inflammation, while Cy3G restored molecular markers, improving cardiac outcomes. The gene discussed is DCN; the disease is myocardial infarction.